SpyGlass Pharma, Inc. (SGP) stock
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$32.88−0.44 (-1.32%)
Close on Nov 13, 2026Market cap $1.10BP/E –Yield –
Earnings
SpyGlass Pharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 25, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$0.73
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of SpyGlass Pharma's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 25, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026before the open | – | – | -$0.73 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026after the close | – | – | -$0.59 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 14, 2026after the close | – | – | -$0.69 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 26, 2026after the close | – | – | -$5.72 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
SpyGlass Pharma has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When SpyGlass Pharma puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases SpyGlass Pharma filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Update
- Results
- Results
- Results
- News
- Update
See a number that looks wrong?